PortfoliosLab logo

Karyopharm Therapeutics Inc.

KPTI
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US48576U1060
CUSIP
48576U106

KPTIPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

KPTIPerformance

The chart shows the growth of $10,000 invested in Karyopharm Therapeutics Inc. on Nov 7, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,676 for a total return of roughly -63.24%. All prices are adjusted for splits and dividends.


KPTI (Karyopharm Therapeutics Inc.)
Benchmark (S&P 500)

KPTIReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M1.72%
6M-45.57%
YTD-61.89%
1Y-59.59%
5Y-9.53%
10Y-11.91%

KPTIMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

KPTISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Karyopharm Therapeutics Inc. Sharpe ratio is -0.96. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


KPTI (Karyopharm Therapeutics Inc.)
Benchmark (S&P 500)

KPTIDividends


KPTI doesn't pay dividends

KPTIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


KPTI (Karyopharm Therapeutics Inc.)
Benchmark (S&P 500)

KPTIWorst Drawdowns

The table below shows the maximum drawdowns of the Karyopharm Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Karyopharm Therapeutics Inc. is 91.26%, recorded on Mar 11, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.26%Jun 16, 20141192Mar 11, 2019
-43.74%Mar 7, 201468Jun 12, 20141Jun 13, 201469
-10.42%Dec 23, 201314Jan 13, 20142Jan 15, 201416
-9.08%Feb 3, 20143Feb 5, 20145Feb 12, 20148
-8.83%Mar 5, 20141Mar 5, 20141Mar 6, 20142
-5.88%Jan 23, 20143Jan 27, 20143Jan 30, 20146
-4.87%Feb 28, 20142Mar 3, 20141Mar 4, 20143
-4.36%Feb 14, 20143Feb 19, 20141Feb 20, 20144
-3.39%Dec 10, 20132Dec 11, 20132Dec 13, 20134
-1.6%Dec 2, 20134Dec 5, 20131Dec 6, 20135

KPTIVolatility Chart

Current Karyopharm Therapeutics Inc. volatility is 53.77%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


KPTI (Karyopharm Therapeutics Inc.)
Benchmark (S&P 500)

Portfolios with Karyopharm Therapeutics Inc.


Loading data...

More Tools for Karyopharm Therapeutics Inc.